Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Statement re: joint broker

2 Mar 2018 13:09

RNS Number : 5668G
Obtala Limited
02 March 2018
 

2 March 2018

Obtala Limited

("Obtala" or the "Company")

(AIM: OBT)

 

Statement re: joint broker

 

Obtala Limited (AIM: OBT), the African focused agricultural and forestry company, notes the Financial Conduct Authority's ("FCA") announcement today regarding Beaufort Securities Limited ("BSL") and Beaufort Asset Clearing Services Limited (the "Firms") being placed into insolvency.

 

The FCA's announcement disclosed that the FCA has imposed requirements requiring the Firms to cease all regulatory activity. BSL were a joint broker to Obtala. As a result of the requirements imposed by the FCA, BSL will no longer be able to provide broking services to Obtala.

 

Northland Capital Partners continue to act as nominated adviser and joint broker to Obtala and Brandon Hill continue to act as joint broker.

 

This Announcement contains inside information for the purposes of Article 7 of the Regulation (EU) 596/2014.

 

 

 

 

Obtala Limited

Miles Pelham - ChairmanPaul Dolan - CEO

Martin Collins - Deputy Chairman

www.obtala.com

 

 

+44 (0)20 7099 1940

Northland Capital Partners Ltd (Nomad and Joint Broker)

Tom Price

David Hignell

 

+44 (0)20 3861 6625

Brandon Hill Capital (Joint Broker)

Jonathan Evans

 

+44 (0)20 3463 5000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRJTMJTMBMMBRP
Date   Source Headline
10th Jun 20227:00 amRNSPublication of Integrated Report
8th Jun 20223:00 pmRNSResults of Annual General Meeting
26th May 20225:55 pmRNSDirector/PDMR Shareholding
25th May 20224:30 pmRNSCorrection: TR-1
23rd May 202212:05 pmRNSTR-1
16th May 20227:00 amRNSWoodbois partners with World Forest ID
12th May 20222:05 pmRNSSecond Price Monitoring Extn
12th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20221:30 pmRNSTR-1
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSNotice of AGM
9th May 20227:00 amRNSConversion of Non-Voting Shares
5th May 20222:49 pmRNSHolding(s) in Company
5th May 20222:06 pmRNSSecond Price Monitoring Extn
5th May 20222:00 pmRNSPrice Monitoring Extension
5th May 202211:05 amRNSSecond Price Monitoring Extn
5th May 202211:00 amRNSPrice Monitoring Extension
5th May 20229:06 amRNSSecond Price Monitoring Extn
5th May 20229:00 amRNSPrice Monitoring Extension
4th May 202210:20 amRNSTR-1
4th May 20229:05 amRNSSecond Price Monitoring Extn
4th May 20229:00 amRNSPrice Monitoring Extension
3rd May 20225:40 pmRNSPDMR Shareholding
29th Apr 20222:12 pmRNSPDMR Shareholding & TR1
25th Apr 20229:05 amRNSSecond Price Monitoring Extn
25th Apr 20229:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 update & Board changes
6th Apr 20223:13 pmRNSTR-1
1st Apr 20227:00 amRNSAudited results for FY 2021
1st Mar 20227:00 amRNSIssue of LTIP’s
13th Jan 20227:00 amRNSQ4 2021 update
26th Nov 20217:00 amRNSTR-1
18th Nov 20217:00 amRNSWoodbois joins The Circular Bioeconomy Alliance
11th Nov 20217:00 amRNSCOP26 Update
8th Nov 20217:00 amRNSAppointment of Chief Executive Officer
1st Nov 20217:00 amRNSAppointment of Independent Non-Executive Director
11th Oct 20217:00 amRNSQ3 2021 Update
30th Sep 20217:00 amRNSMembership of the European Forest Institute
23rd Sep 20217:00 amRNSInvestor Conference
16th Aug 20217:00 amRNSInvestor Presentation
12th Aug 202110:22 amRNSHolding(s) in Company
11th Aug 20217:00 amRNSHalf Year Results
9th Aug 20217:00 amRNSGabon forest interests increased by 75%
29th Jul 20214:41 pmRNSSecond Price Monitoring Extn
29th Jul 20214:36 pmRNSPrice Monitoring Extension
7th Jul 20217:00 amRNSQ2 2021 Update
29th Jun 20217:00 amRNSSPOTT Transparency Assessment
23rd Jun 202112:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.